221.50
price up icon0.61%   1.34
after-market 시간 외 거래: 217.00 -4.50 -2.03%
loading
전일 마감가:
$220.16
열려 있는:
$218.17
하루 거래량:
978.96K
Relative Volume:
1.10
시가총액:
$15.92B
수익:
$2.88B
순이익/손실:
$499.60M
주가수익비율:
32.86
EPS:
6.74
순현금흐름:
$321.60M
1주 성능:
-1.52%
1개월 성능:
-4.67%
6개월 성능:
-26.12%
1년 성능:
-42.90%
1일 변동 폭
Value
$216.63
$224.02
1주일 범위
Value
$216.63
$227.57
52주 변동 폭
Value
$197.01
$396.75

West Pharmaceutical Services Inc Stock (WST) Company Profile

Name
명칭
West Pharmaceutical Services Inc
Name
전화
(610) 594-2900
Name
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Name
직원
0
Name
트위터
@WestPharma
Name
다음 수익 날짜
2024-10-24
Name
최신 SEC 제출 서류
Name
WST's Discussions on Twitter

WST을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
221.50 15.92B 2.88B 499.60M 321.60M 6.74
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
507.05 177.83B 8.35B 2.32B 1.30B 6.41
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
226.42 66.11B 20.64B 1.73B 2.94B 6.02
Medical Instruments & Supplies icon
ALC
Alcon Inc
92.59 45.80B 9.91B 1.02B 665.00M 2.05
Medical Instruments & Supplies icon
RMD
Resmed Inc
223.00 32.66B 4.93B 1.25B 1.38B 8.47
Medical Instruments & Supplies icon
BAX
Baxter International Inc
33.65 17.26B 17.28B 108.00M 391.00M 0.20

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-03-18 개시 Evercore ISI Outperform
2025-02-14 업그레이드 Deutsche Bank Hold → Buy
2025-01-08 개시 Citigroup Buy
2024-12-13 개시 Wolfe Research Peer Perform
2024-12-12 업그레이드 UBS Neutral → Buy
2024-02-07 업그레이드 Jefferies Hold → Buy
2023-06-16 업그레이드 BofA Securities Neutral → Buy
2023-04-11 업그레이드 Stephens Equal-Weight → Overweight
2022-12-14 개시 Deutsche Bank Hold
2022-11-30 개시 UBS Neutral
2022-10-28 다운그레이드 BofA Securities Buy → Neutral
2020-11-10 개시 KeyBanc Capital Markets Overweight
2020-10-14 개시 Stephens Equal-Weight
2020-07-21 업그레이드 BofA Securities Neutral → Buy
2020-04-24 업그레이드 BofA/Merrill Underperform → Neutral
2019-12-12 다운그레이드 BofA/Merrill Neutral → Underperform
2019-07-26 업그레이드 BofA/Merrill Underperform → Neutral
2019-05-01 다운그레이드 Jefferies Buy → Hold
2019-04-23 개시 William Blair Outperform
2018-04-25 다운그레이드 BofA/Merrill Neutral → Underperform
2018-01-24 개시 Goldman Neutral
2017-10-17 다운그레이드 BofA/Merrill Buy → Neutral
2017-10-03 개시 Stephens Equal-Weight
2017-09-15 업그레이드 Jefferies Hold → Buy
2016-10-28 업그레이드 Wells Fargo Market Perform → Outperform
2016-09-21 다운그레이드 Wells Fargo Outperform → Market Perform
2016-03-22 개시 Wells Fargo Outperform
2010-05-14 재확인 UBS Neutral
2010-02-23 개시 Jefferies & Co Buy
2008-12-19 개시 UBS Neutral
모두보기

West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스

pulisher
Apr 02, 2025

West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud AllegationsWST - ACCESS Newswire

Apr 02, 2025
pulisher
Apr 02, 2025

National Wealth Management Group LLC Makes New $706,000 Investment in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat

Apr 02, 2025
pulisher
Apr 02, 2025

Pharmaceutical Testing Services Market Set to Witness - openPR.com

Apr 02, 2025
pulisher
Mar 31, 2025

WST ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your West Pharmaceutical Services, Inc. investment - ACCESS Newswire

Mar 31, 2025
pulisher
Mar 28, 2025

How Is The Market Feeling About West Pharmaceutical Servs? - Benzinga

Mar 28, 2025
pulisher
Mar 26, 2025

West Pharmaceutical Services, Inc. (WST) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights - ACCESS Newswire

Mar 26, 2025
pulisher
Mar 25, 2025

Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks - Yahoo Finance

Mar 25, 2025
pulisher
Mar 22, 2025

West Pharmaceutical Services (NYSE:WST) Proposes Bylaw Changes; Share Price Remains Flat - Yahoo Finance

Mar 22, 2025
pulisher
Mar 21, 2025

Is West Pharmaceutical Services Stock Underperforming the S&P 500? - Nasdaq

Mar 21, 2025
pulisher
Mar 21, 2025

Is West Pharmaceutical Services Stock Underperforming The S&P 500? - Barchart

Mar 21, 2025
pulisher
Mar 19, 2025

West Pharmaceutical at KeyBanc Forum: Strategic Growth Amid Challenges - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

West Pharmaceutical at KeyBanc Forum: Strategic Growth Amid Challenges By Investing.com - Investing.com UK

Mar 19, 2025
pulisher
Mar 19, 2025

UBS maintains Buy on West Pharma, reiterates $285 target By Investing.com - Investing.com Canada

Mar 19, 2025
pulisher
Mar 19, 2025

UBS maintains Buy on West Pharma, reiterates $285 target - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

Did West Pharmaceutical Services, Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate- WST - ACCESS Newswire

Mar 19, 2025
pulisher
Mar 18, 2025

This West Pharmaceutical Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga India

Mar 18, 2025
pulisher
Mar 18, 2025

Evercore ISI sets $275 target on West Pharmaceutical stock - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

Evercore ISI sets $275 target on West Pharmaceutical stock By Investing.com - Investing.com UK

Mar 18, 2025
pulisher
Mar 18, 2025

Evercore ISI Initiates West Pharmaceutical Services at Outperform With $275 Price Target - MarketScreener

Mar 18, 2025
pulisher
Mar 13, 2025

Managing Risks In Injectable Drug Delivery Solutions For Todays Drug Products And Tomorrows Novel Applications - Bioprocess Online

Mar 13, 2025
pulisher
Mar 12, 2025

West Pharmaceutical at Barclays Healthcare: Strategic Growth Amid Challenges - Investing.com India

Mar 12, 2025
pulisher
Mar 12, 2025

West Pharmaceutical at Barclays Healthcare: Strategic Growth Amid Challenges By Investing.com - Investing.com South Africa

Mar 12, 2025
pulisher
Mar 12, 2025

West Pharmaceutical Services, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your RightsWST - ACCESS Newswire

Mar 12, 2025
pulisher
Mar 12, 2025

On-Body Drug Delivery Devices Market to Hit $ 82.74 Bn by 2033Key - openPR

Mar 12, 2025
pulisher
Mar 12, 2025

Jones Financial Companies Lllp Grows Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World

Mar 12, 2025
pulisher
Mar 11, 2025

West Pharmaceutical Announces Leadership Transition - TipRanks

Mar 11, 2025
pulisher
Mar 11, 2025

Meeting Annex 1 Regulations: A Proactive Approach To Regulatory Compliance - Med Device Online

Mar 11, 2025
pulisher
Mar 11, 2025

Lost Money on West Pharmaceutical Services, Inc. (WST)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire

Mar 11, 2025
pulisher
Mar 11, 2025

West Pharmaceutical: Remains A Strong Long-Term Prospect (NYSE:WST) - Seeking Alpha

Mar 11, 2025
pulisher
Mar 10, 2025

West Pharmaceutical Services to Present at Major 2025 Healthcare Conferences - MSN

Mar 10, 2025
pulisher
Mar 10, 2025

Zacks Research Has Bearish Estimate for WST Q1 Earnings - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Why West Pharmaceutical Services, Inc. (WST) Is Plunging So Far In 2025 - Insider Monkey

Mar 09, 2025
pulisher
Mar 09, 2025

A Look At The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST) - Yahoo Finance

Mar 09, 2025
pulisher
Mar 09, 2025

FY2027 Earnings Forecast for WST Issued By Zacks Research - Defense World

Mar 09, 2025
pulisher
Mar 05, 2025

West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet - Simply Wall St

Mar 05, 2025
pulisher
Mar 05, 2025

West to Participate in Upcoming Investor Conferences -March 05, 2025 at 06:01 am EST - Marketscreener.com

Mar 05, 2025
pulisher
Mar 05, 2025

West to Participate in Upcoming Investor Conferences - Quantisnow

Mar 05, 2025
pulisher
Mar 05, 2025

West Pharmaceutical Sets Key Investor Conference ScheduleHow to Access Their March Presentations - Stock Titan

Mar 05, 2025
pulisher
Mar 04, 2025

Lost Money on West Pharmaceutical Services, Inc.(WST)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire

Mar 04, 2025
pulisher
Mar 04, 2025

Private Advisor Group LLC Trims Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World

Mar 04, 2025
pulisher
Mar 04, 2025

Achieving EU GMP Annex 1 Compliance Through An End-To-End Approach To Contamination Control - Med Device Online

Mar 04, 2025
pulisher
Mar 01, 2025

West Pharmaceutical Services, Inc. (NYSE:WST) Receives $344.00 Consensus Target Price from Brokerages - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain - Morningstar

Feb 28, 2025
pulisher
Feb 28, 2025

Do Wall Street Analysts Like West Pharmaceutical Services Stock? - MSN

Feb 28, 2025
pulisher
Feb 28, 2025

Levi & Korsinsky Investigates Possible Securities Fraud Violations by West Pharmaceutical Services, Inc. (WST) - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 25, 2025

Healthcare Visual Inspection Services Market Report, 2030 - Grand View Research

Feb 25, 2025

West Pharmaceutical Services Inc (WST) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
medical_instruments_supplies COO
$81.23
price down icon 0.05%
medical_instruments_supplies BAX
$33.65
price down icon 1.09%
$60.56
price down icon 1.34%
$76.62
price up icon 0.37%
$163.98
price up icon 3.73%
자본화:     |  볼륨(24시간):